Cassoli, Juliana Silva http://orcid.org/0000-0002-2174-6309
Guest, Paul C
Malchow, Berend
Schmitt, Andrea
Falkai, Peter
Martins-de-Souza, Daniel
Article History
Received: 1 July 2015
Revised: 10 August 2015
Accepted: 19 August 2015
First Online: 23 September 2015
Competing interests
: AS was an honorary speaker for TAD Pharma and Roche and has been a member of advisory boards for Roche. PF has been an honorary speaker for AstraZeneca, Bristol Myers Squibb, Eli Lilly, Essex, GE Healthcare, GlaxoSmithKline, Janssen Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Takeda. During the past 5 years, but not presently, PF has been a member of the advisory boards of Janssen Cilag, AstraZeneca, Eli Lilly, and Lundbeck. The remaining authors declare no conflict of interest.